Shandong Weigao Group Medical Polymer Co. Ltd. will hold its first extraordinary general meeting of 2026 on 12 February 2026 at its premises in Weihai, Shandong Province, the PRC. During the meeting, shareholders will consider and vote on the approval, confirmation, and ratification of the Sale and Purchase Agreement (comprising the Original Sale and Purchase Agreement and the Supplemental Sale and Purchase Agreement), the Compensation Agreement, and the Letter of Non-Competition Undertakings, all dated 5 January 2026. Additionally, the meeting will authorize any one director to take necessary actions and sign documents required to implement the transaction documents and the transactions contemplated therein.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Weigao Group Medical Polymer Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260126-12000907), on January 26, 2026, and is solely responsible for the information contained therein.
Comments